Skip to content
AwardedFinlandGoods

Palopegteriparatidivalmisteen (Yorvipath) hankinta

Published
Published 18 December 2025

Overview

Palopegteriparatidivalmisteen (Yorvipath ®) hankinta valmisteyhteenvedon mukaiseen käyttöön kroonista hypoparatyreoosia sairastavien aikuisten hoitoon. Hankintarenkaassa on mukana HUS-yhtymä (HUS), HUS-yhtymän omistajajäsenet (Helsingin kaupunki, Itä-Uudenmaanhyvinvointialue, Keski-Uudenmaan hyvinvointialue, Vantaan ja Keravan hyvinvointialue sekä Länsi-Uudenmaan hyvinvointialue), Etelä-Karjalan hyvinvointialue, Kymenlaakson hyvinvointialue ja Päijät-Hämeen hyvinvointialue.

Key details

Country
Finland
Status
Awarded
Category
Goods
Procedure
Direct
Published
18 December 2025
Classification (CPV)
Pharmaceutical products

Award outcome

Awarded value
€760,000
Award date
29 December 2025
Contract period
— → 31 December 2026
Winner
  • Ascendis Pharma A/S

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    29 January 2026

  2. Contract Notice

    18 December 2025

Contracting authority

  • HUS Group, the joint authority for Helsinki and Uusimaa

    Procuring entity

    Helsinki, Finland

    Authority website ↗

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: Palopegteriparatidivalmisteen (Yorvipath) hankinta — won by Ascendis Pharma A/S — Skim